Table 1.
Baseline patient characteristics stratified by mortality status up to three months.
| Characteristic | Alive(n = 1030) | Dead(n = 241) | p value |
|---|---|---|---|
| Women | 601 (58.4) | 121 (50.2) | 0.022 |
| Age | 71.1 (11.0) | 77.5 (10.4) | 0.001 |
| History of | |||
| Hypertension | 750 (72.8) | 158 (65.6) | 0.025 |
| Diabetes | 319 (31.0) | 68 (28.2) | 0.403 |
| Dyslipidaemia | 351 (34.1) | 47 (19.5) | 0.001 |
| Smoking | 341 (33.1) | 56 (23.2) | 0.003 |
| Transient ischaemic attack | 130 (12.6) | 20 (8.30) | 0.061 |
| Coronary artery disease | 226 (21.9) | 58 (24.1) | 0.476 |
| Atrial fibrillation | 415 (40.3) | 134 (55.6) | 0.001 |
| Admission values | |||
| NIHSSb | 6 (13) | 22 (10) | 0.001 |
| eGFRb | 75 (40) | 60 (46) | 0.001 |
| Stroke classification (TOAST) | |||
| Lacunar | 189 (18.3) | 2 (0.8) | 0.001 |
| Large vessel atherosclerosis | 199 (19.3) | 27 (11.2) | 0.001 |
| Cardioembolism | 429 (41.7) | 148 (61.4) | 0.001 |
| Undetermined aetiology | 196 (19.0) | 63 (26.1) | 0.016 |
| Other aetiology | 17 (1.7) | 1 (0.4) | 0.117 |
| In-hospital treatment | |||
| Thrombolysis | 27 (2.6) | 5 (2.1) | 0.626 |
| Aspirin | 837 (81.3) | 182 (75.5) | 0.044 |
| LMWH | 711 (69.0) | 136 (56.4) | 0.001 |
NIHSS: National Institute of Health Stroke Scale; eGFR: estimated glomerular filtration rate (mL/min/1.73 m2); LMWH: low molecular weight heparin (for deep venous thrombosis prophylaxis).
aNumbers in parentheses for nominal data indicate percentages. Continuous variables are expressed as mean ± standard deviation except than non-normally distributed variables.
bDescribed as median (inter-quartile range).